ARTICLE | Company News
Celera Genomics Group, Aventis deal
January 14, 2002 8:00 AM UTC
CRA received the fourth and final milestone payment from AVE under the companies' 1998 Cathepsin S inhibitor collaboration. The milestone was triggered by AVE's selection of individual Cathepsin S in...